stock
Advertisement
finance

FICO: A Closer Look at the Numbers

December 6, 2025

FICO, a big name in tech, is getting some attention from analysts. One expert, Ashish Sabadra, thinks it's a good time to invest. He gave it a "Buy" rating and predicts the stock could reach $2, 400. Right now, it's trading at $1, 771. 87. But what's the bigger picture? Well, most analysts seem to

business

Twenty One Capital Set to Hit the Stock Market

December 5, 2025

Twenty One Capital, Inc. is on the brink of becoming a publicly traded company. This follows the green light from shareholders of Cantor Equity Partners, Inc. (CEP) for a merger between the two firms. The approval came through during an Extraordinary General Meeting held on December 3rd. The merger

finance

Revolution Medicines: A Rising Star in Cancer Research

December 5, 2025

Revolution Medicines (RVMD) has been making waves in the stock market, reaching new heights. The company is valued at $15 billion and is focused on developing treatments for cancers caused by mutations in RAS proteins. This is a big deal because these types of cancers are tough to treat. The stock

finance

Cobalt Prices Skyrocket, U. S. Defense Agency Reevaluates Stockpile Plans

December 5, 2025

The U. S. Defense Logistics Agency (DLA) is taking a step back to rethink its cobalt purchasing strategy. With cobalt prices surging by 50% since August, the agency is now reassessing its plans to stockpile this crucial metal. The DLA's initial tender, which aimed to purchase 7, 480 metric tons of c

finance

Trump's Crypto Bet: A Roller Coaster Ride

December 4, 2025

The Trump family's financial ventures have hit a rough patch lately. Their assets aren't doing as well as the rest of the market. This is especially true for their crypto investments. Eric Trump's American Bitcoin (ABTC) took a big hit. It dropped almost 50% in early trading on Tuesday. By the end o

health

A New Hope in Lung Cancer Treatment

December 4, 2025

Black Diamond Therapeutics has shared some promising news about their drug, silevertinib. It's being tested on people with a specific type of lung cancer. The results from the second phase of trials show that 60% of patients responded well to the treatment. This includes 25 partial responses and one

finance

Super Micro Computer: Is the Tech Giant Losing Its Edge?

December 3, 2025

Super Micro Computer, Inc. (SMCI), a major player in the tech world, is facing some tough times. Based in San Jose, California, SMCI is known for making high-performance servers and storage solutions. With a market cap of $19. 9 billion, it's definitely a big fish in the tech pond. But lately, its s

crypto

Crypto Stocks: Why American Bitcoin Might Not Be a Smart Buy

December 3, 2025

American Bitcoin (ABTC) shares took a big hit, dropping nearly 49% recently. This isn't just a small dip. It's part of a much bigger problem in the crypto world. Bitcoin itself has fallen about 30% from its peak earlier this year. This drop has caused a lot of trouble, with over $19 billion lost and

crypto

Bitcoin's Big Bounce: What's Driving the Crypto Surge?

December 3, 2025

Bitcoin's value jumped by around 6% in just one day. This sudden rise caught the attention of many investors and traders. It also led to a lot of activity in crypto-related exchange-traded funds (ETFs). Among them, BlackRock’s iShares Bitcoin Trust (IBIT) stood out. It saw a huge trading volume of a

business

What's the Deal with Ubisoft's Stock?

December 3, 2025

Ubisoft's stock is in the spotlight again. Barclays' Nick Dempsey has kept his Hold rating on the company, setting a price target of €6. 40. This news comes after a recent report from Dempsey, who is known for his decent track record in the Communication Services sector. Dempsey isn't the only one